Filgrastim Terminated Phase 2 Trials for Multiple Myeloma (MM) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00681044HD Melphalan and SCT in Patients With IGDD or LCDD
NCT02112045A Study of Granix to Disrupt the Bone Marrow Microenvironment in Patients With Multiple Myeloma Undergoing Autologous Transplantation